S Mishra, K Rox - ACS Pharmacology & Translational Science, 2024 - ACS Publications
Despite the end of COVID-19 pandemic, only intravenous remdesivir was approved for
treatment of vulnerable pediatric populations. Molnupiravir is effective against viruses …